United Therapeutics Corp
UTHRHealthcare|Drug Manufacturers - Specialty & Generic|USA
$547.06
-5.42 (-0.98%)
DCF (FCF)
$355.12
Tangible Book
$137.24
Graham Number
$291.18
Earnings Power
$241.84
Upcoming Data Readouts (52)
Aug 2026
Est. completion
Abnormal Vascular Flow
A Pilot Study to Evaluate Multi-Spectral and Laser Speckle Imaging and Multiphoton Microscopy During Vascular Occlusion
NCT01484730n=150
Aug 2026
Est. completion
Sep 2026
Est. completion
NAMuscle Disuse
Muscle Response to Different Amounts of Dietary Protein During Leg Immobilization
NCT07069426n=28
Sep 2026
Est. completion
Spinal Cord Injuries
SCIVAX: Biomarkers of Immune Dysfunction and Vaccine Responsiveness in Chronic SCI
NCT05869968n=140
Oct 2026
Est. completion
NASpinal Cord Injuries
Neuropathic Pain and Operant Conditioning of Cutaneous Reflexes After SCI
NCT05492188n=15
Oct 2026
Est. completion
P2Advanced Clear Cell Renal Cell Carcinoma
Genetic Testing to Select Therapy for the Treatment of Advanced or Metastatic Kidney Cancer, OPTIC RCC Study
NCT05361720n=54
Nov 2026
Est. completion
NAType II Diabetes Mellitus
Feasibility Trial in Urban Pakistan for Community Engagement in Preventing Type II Diabetes and Risk Factors
NCT06570057n=240
Dec 2026
Est. completion
Dec 2026
Est. completion
Dec 2026
Est. completion
Dec 2026
Est. completion
NADepression - Major Depressive Disorder
No Time to Wait: Single Session Intervention
NCT07383467n=124
Dec 2026
Est. completion
P2Anatomic Stage I Breast Cancer AJCC v8
Concurrent WOKVAC Vaccination, Chemotherapy, and HER2-Targeted Monoclonal Antibody Therapy Before Surgery for the Treatment of Patients With Breast Cancer
NCT04329065n=25
Jan 2027
Est. completion
Feb 2027
Est. completion
Mar 2027
Est. completion
NAPTSD
A Trial Comparing Interpersonal Therapy to Exposure Therapy for PTSD Due to Military Sexual Trauma (MST) in Male and Female Military Personnel
NCT03803332n=208
Mar 2027
Est. completion
P3Sickle Cell Disease
RElated Haplo-DonoR Haematopoietic stEm Cell Transplantation for Adults With Severe Sickle Cell Disease
NCT05392894n=120
Mar 2027
Est. completion
P2Ovarian Clear Cell Adenocarcinoma
Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer
NCT05231122n=80
Mar 2027
Est. completion
NAProstate Cancer
Improving Health Literacy in African-American Prostate Cancer Patients
NCT03322891n=210
Mar 2027
Est. completion
May 2027
Est. completion
Musculoskeletal Injuries
Pre- and Post-neuromusculoskeletal Injury Risk Evaluation for Return-to-Duty Enhancement
NCT05111925n=2,690
Awaiting Results (13)
Trials past primary completion date but still active — data readout may be imminent.
Jun 2026
Transforming Research and Clinical Knowledge in Traumatic Brain Injury Epileptogenesis Project (TRACK-TBI EPI)
NCT05823766Dec 2024
Digitally Captured Activity Data and PROs to Monitor Physical Function in Prostate Cancer Patients
NCT04575402Feb 2023
P2
Preoperative Fulvestrant With or Without Enzalutamide in ER+/Her2- Breast Cancer
NCT02955394